Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02138838
What this trial is testing

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 55
Large-scale testing (Phase 3)Study completedNCT00772382
What this trial is testing

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 116
Early research (Phase 1)Study completedNCT02347046
What this trial is testing

Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)

Who this might be right for
Renal InsufficiencyHealthy
Fuji Yakuhin Co., Ltd. 18
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Early research (Phase 1)Ended earlyNCT01675973
What this trial is testing

Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

Who this might be right for
Severe Renal Impairment
Gilead Sciences 4
Early research (Phase 1)UnknownNCT05947097
What this trial is testing

Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 32
Not applicableStudy completedNCT01623661
What this trial is testing

Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease

Who this might be right for
Nephropathy
Regional Hospital Holstebro 47
Not applicableStudy completedNCT02460263
What this trial is testing

The EvAluation of TaBlo In-CLinic and In-HOme

Who this might be right for
End Stage Renal Disease
Outset Medical 30
Not applicableUnknownNCT06106126
What this trial is testing

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 32
Post-approval studies (Phase 4)Study completedNCT00132431
What this trial is testing

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

Who this might be right for
Kidney DiseaseSecondary HyperparathyroidismChronic Kidney Disease
Amgen 300
Large-scale testing (Phase 3)Ended earlyNCT00451295
What this trial is testing

A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 6
Early research (Phase 1)Study completedNCT04476849
What this trial is testing

Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 27
Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Early research (Phase 1)Study completedNCT03660241
What this trial is testing

A Renal Impairment Study for PF-04965842

Who this might be right for
Renal Impairment
Pfizer 23
Early research (Phase 1)Study completedNCT05704556
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment

Who this might be right for
Pain
Vertex Pharmaceuticals Incorporated 38
Testing effectiveness (Phase 2)Study completedNCT01147666
What this trial is testing

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Who this might be right for
End Stage Renal DiseaseAnemia
Kyntra Bio 161
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Large-scale testing (Phase 3)Study completedNCT01020487
What this trial is testing

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease Stage 3 and 4
AbbVie (prior sponsor, Abbott) 47
Early research (Phase 1)Study completedNCT06657560
What this trial is testing

Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Contrast-Enhanced Magnetic Resonance Imaging Detection
Shanghai Shengdi Pharmaceutical Co., Ltd 41
Testing effectiveness (Phase 2)Study completedNCT01407874
What this trial is testing

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

Who this might be right for
GoutHyperuricemiaArthritis+2 more
BioCryst Pharmaceuticals 20
Next Page